Archive for the ‘informa healthcare’ Category
Here’s the retraction notice for “Odanacatib for the treatment of postmenopausal osteoporosis, a paper originally published in Expert Opinion on Pharmacotherapy:
Unfortunately, due to an honest error from the author, a small portion of this otherwise reliable published article contains clinically inaccurate data. The publisher and author agree to retract the paper pending correction.
The author of the paper, Roland Chapurlat, tells us: Read the rest of this entry »
A pair of authors from Italy has retracted their 2012 article in the Journal of Maternal-Fetal and Neonatal Medicine for including chunks of text with a “high degree of similarity” from other published sources. But rest assured: the authors, we’re told, didn’t intend to do so.
The article, “Central venous catheterization and thrombosis in newborns: update on diagnosis and management,” appeared in a supplemental issue of the journal covering the proceedings of the XVIII Congress of the Italian Society of Neonatology.
The journal Clinical Research and Regulatory Affairs has retracted a 2012 article on over-the-counter drugs by a trio of pharmacy researchers in India who decided to “reproduce content to a high degree of similarity” from other sources.
We’ve come across some odd examples of plagiarism in this job, from the fellow who tried to build a CV on the back of another researcher’s work, to the education researcher who, from what we can tell, preferred lifting the work of others to writing her own papers. Here’s another odd one for the pile.
A group of Iranian scholars has lost a paper in Brain Injury because they lifted it wholesale from a previously published article. What’s harder to get one’s mind around, however, is that the two papers were looking at culturally-specific aspects of brain injury. Except that one wasn’t.
The retracted paper, “Frontal acquired brain injury, substance abuse and their common psychological symptoms in the Iranian population,” appeared in 2011. Here’s the abstract, which is still available on the journal’s website (we’ll note that although the abstract is free for all, the retraction notice was behind a pay wall — an error, according to the publisher, which they remedied when we contacted them): Read the rest of this entry »
The article, “Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome,” came from oncologists at the National Medical Center. Its abstract (still available on Medline) states: Read the rest of this entry »
The article, “Testosterone therapy improves psychological distress and health-related quality of life in Chinese men with symptomatic late-onset hypogonadism patients,” came from a group at Peking University People’s Hospital, in Beijing.
But as the retraction notice explains: Read the rest of this entry »
Pharmaceutical Biology has retracted a 2012 paper by a group of liver researchers from China after the discovery of an error that evidently invalidated the results in the paper.
The article, “Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis,” purported to show that
protocatechuic aldehyde, the major degradation of phenolic acids … has potentially conferring antifibrogenic effects.
The research involved looking at concentrations of blood fats in athletes and less vigorous folk, “and to examine the risks of cardiovascular diseases.”It found that:
… medium and high level of exercises did not cause significant differences in lipid and lipoprotein levels, but the sex differences were very pronounced” with “lipid and lipoprotein profile of female subjects was found to be better than that of males”.